CVT-12012
- CAS No.
- 1018675-35-8
- Chemical Name:
- CVT-12012
- Synonyms
- CS-2863;CVT-2012;CVT-12012;CVT-12012, 10 mM in DMSO;CVT 12012,Stearoyl-CoA Desaturase (SCD),inhibit,CVT12012,Inhibitor,CVT-12012;2-hydroxy-N-[2-[3-methyl-2-oxo-7-[[3-(trifluoromethyl)phenyl]methylamino]quinoxalin-1-yl]ethyl]acetamide;2-Hydroxy-N-[2-[3-methyl-2-oxo-7-[[[3-(trifluoromethyl)phenyl]methyl]amino]-1(2H)-quinoxalinyl]ethyl]acetamide;Acetamide, 2-hydroxy-N-[2-[3-methyl-2-oxo-7-[[[3-(trifluoromethyl)phenyl]methyl]amino]-1(2H)-quinoxalinyl]ethyl]-;2-Hydroxy-N-(2-(3-methyl-2-oxo-7-(((3-(trifluoromethyl)phenyl)methyl)amino)-1,2-dihydroquinoxalin-1-yl)ethyl)acetamide
- CBNumber:
- CB02627711
- Molecular Formula:
- C21H21F3N4O3
- Molecular Weight:
- 434.41
- MDL Number:
- MOL File:
- 1018675-35-8.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| Density | 1.37±0.1 g/cm3(Predicted) |
|---|---|
| storage temp. | Store at -20°C |
| solubility | DMF: 30 mg/ml; DMSO: 30 mg/ml; DMSO:PBS (pH 7.2) (1:6): 0.14 mg/ml; Ethanol: 1 mg/ml |
| form | A crystalline solid |
| pka | 13.29±0.10(Predicted) |
| color | Light yellow to yellow |
| FDA UNII | OH3J29Q653 |
CVT-12012 price More Price(31)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 27156 | CVT-12012 ≥98% | 1018675-35-8 | 1mg | $36 | 2026-04-30 | Buy |
| Cayman Chemical | 27156 | CVT-12012 ≥98% | 1018675-35-8 | 5mg | $153 | 2026-04-30 | Buy |
| Cayman Chemical | 27156 | CVT-12012 ≥98% | 1018675-35-8 | 10mg | $268 | 2026-04-30 | Buy |
| Cayman Chemical | 27156 | CVT-12012 ≥98% | 1018675-35-8 | 25mg | $587 | 2026-04-30 | Buy |
| Biosynth | TQB67535 | CVT-12012 | 1018675-35-8 | 25mg | $905.25 | 2026-06-05 | Buy |
CVT-12012 Chemical Properties, Uses, Production
Uses
CVT-12012 is a potent and orally bioavailable stearoyl-coA desaturase (SCD) inhibitor, with IC50s of 38 nM, 6.1 nM for rat microsomal and human HEPG2, respectively.
in vivo
In a rat PK study, CVT-12012 demonstrates good oral bioavailability (78%). It appears that the oral absorption of CVT-12012 is not affected by a significant Pgp efflux, which is expected based on Caco-2 assay result. The plasma clearance of CVT-12012 is high (88 mL/min/kg) with elimination half-life of approximately 1 h[1].
References
[1] Koltun DO, et al. Potent, orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitors. Bioorg Med Chem Lett. 2009 Aug 1;19(15):4070-4. DOI:10.1016/j.bmcl.2009.06.017
[2] Atkinson KA, et al. N-benzylimidazole carboxamides as potent, orally active stearoylCoA desaturase-1 inhibitors. Bioorg Med Chem Lett. 2011 Mar 15;21(6):1621-5. DOI:10.1016/j.bmcl.2011.01.113
CVT-12012 Preparation Products And Raw materials
Raw materials
Preparation Products
CVT-12012 Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Shanghai Lollane Biological Technology Co.,Ltd. | 021-52996696，15000506266 15000506266 | China | 4859 | 55 | |
| Shanghai YuanYe Biotechnology Co., Ltd. | 15026964105 | 2881489226@qq.com | China | 89667 | 60 |
| ShangHai Biochempartner Co.,Ltd | 177-54423994 17754423994 | 2853530910@QQ.com | China | 8000 | 62 |
| Chuzhou KeMail Chemical Technology Co., Ltd | 0550-5196001 15000891977 | wj520wjxby@126.com | China | 1940 | 55 |
| Dezhou LonWel Pharmaceutical Technology Co., Ltd. | 13761310616 | 39324283@qq.com | China | 1365 | 58 |
| Twochem Co.Ltd. | 021-58111628 15800915896 | sales@twochem.com | China | 1782 | 58 |
| Taizhou Crene Biotechnology Co. Ltd. | +86-0576-88813233 +86-13396860566 | sales@pharm-intermediates.com | China | 1976 | 58 |
| Aishilun biotechnology (Shanghai) co., LTD | 021-50676523 18019098996 | info@acelybio.com | China | 3950 | 58 |
| Tianjin Kaifu Pharmaceutical Technology Co., Ltd. | 18081075745 | chemflowtech@sina.com | China | 1883 | 58 |
| BOC Sciences | 16314854226; +8616314854226 | inquiry@bocsci.com | United States | 19852 | 58 |
